Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview-Reference-Cited by-同舟云学术

Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview

Published:2017-07-14 Issue:2 Volume:17 Page:247-253
ISSN:1389-9600
Container-title:Familial Cancer
language:en
Short-container-title:Familial Cancer

Author:

Farag S.^ORCID,van der Kolk L. E.,van Boven H. H.,van Akkooi A. C. J.,Beets G. L.,Wilmink J. W.,Steeghs N.

Funder

Novartis Pharma

Pfizer

Bayer

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics (clinical),Oncology,Genetics

Link

http://link.springer.com/article/10.1007/s10689-017-0024-8/fulltext.html

Reference34 articles.

1. Joensuu H, Hohenberger P, Corless CL (2013) Gastrointestinal stromal tumour. Lancet 382:973–983

2. Corless CL (2014) Gastrointestinal stromal tumors: what do we know now? Mod Pathol 27(Suppl 1):S1–S16

3. Joensuu H, Eriksson M, Sundby Hall K et al (2012) One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA 307:1265–1272

4. Joensuu H, Vehtari A, Riihimäki J, Nishida T, Steigen SE, Brabec P et al (2012) Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol 13:265–274

5. Hirota S, Okazaki T, Kitumara Y, O’Brien P, Kapusta L, Dardick I (2000) Cause of familial and multiple gastrointestinal autonomic nerve tumors with hyperplasia of interstitial cells of Cajal is germline mutation of the c-kit gene. Am J Surg Pathol 24:326–327

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Síndrome de GIST hereditario y secundario a una mutación germinal en KIT;Gastroenterología y Hepatología;2023-10

2. Hereditary GIST syndrome secondary to germline mutation in KIT;Gastroenterología y Hepatología (English Edition);2023-10

3. Diagnosis, Treatment, and Prognosis of Patients with Primary Familial Gastrointestinal Stromal Tumor: A Case Report and Literature Review;The Oncologist;2023-06-13

4. A literature review and database of how the primary KIT/PDGFRA variant of a gastrointestinal stromal tumour predicts for sensitivity to imatinib;Cancer Genetics;2022-11

5. KIT-Associated Familial GIST Syndrome: Response to Tyrosine Kinase Inhibitors and Implications for Risk Management;The Oncologist;2022-07-06